238 related articles for article (PubMed ID: 19318422)
21. Serum antibodies to periodontal pathogens and markers of systemic inflammation.
Dye BA; Choudhary K; Shea S; Papapanou PN
J Clin Periodontol; 2005 Dec; 32(12):1189-99. PubMed ID: 16268994
[TBL] [Abstract][Full Text] [Related]
22. Serum markers of periodontal disease status and inflammation in hemodialysis patients.
Rahmati MA; Craig RG; Homel P; Kaysen GA; Levin NW
Am J Kidney Dis; 2002 Nov; 40(5):983-9. PubMed ID: 12407643
[TBL] [Abstract][Full Text] [Related]
23. C-reactive protein associated with periodontitis in a Thai population.
Pitiphat W; Savetsilp W; Wara-Aswapati N
J Clin Periodontol; 2008 Feb; 35(2):120-5. PubMed ID: 18081858
[TBL] [Abstract][Full Text] [Related]
24. Impact of genetic variants of CD14 and TLR4 on subgingival periodontopathogens.
Schulz S; Zissler N; Altermann W; Klapproth J; Zimmermann U; Gläser C; Schaller HG; Reichert S
Int J Immunogenet; 2008 Dec; 35(6):457-64. PubMed ID: 19046305
[TBL] [Abstract][Full Text] [Related]
25. Assessing the levels of immunoglobulins in the saliva of diabetic individuals with periodontitis using checkerboard immunodetection.
Bachrach G; Muster Z; Raz I; Chaushu G; Stabholz A; Nussbaum G; Gutner M; Chaushu S
Oral Dis; 2008 Jan; 14(1):51-9. PubMed ID: 18173449
[TBL] [Abstract][Full Text] [Related]
26. Porphyromonas gingivalis (Pg) a possible link between impaired oral health and acute myocardial infarction.
Holmlund A; Hedin M; Pussinen PJ; Lerner UH; Lind L
Int J Cardiol; 2011 Apr; 148(2):148-53. PubMed ID: 19913930
[TBL] [Abstract][Full Text] [Related]
27. The differential effect of genetic variation on soluble CD14 levels in human plasma and milk.
Guerra S; Carla Lohman I; LeVan TD; Wright AL; Martinez FD; Halonen M
Am J Reprod Immunol; 2004 Sep; 52(3):204-11. PubMed ID: 15373760
[TBL] [Abstract][Full Text] [Related]
28. Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis.
Mikuls TR; LeVan TD; Sayles H; Yu F; Caplan L; Cannon GW; Kerr GS; Reimold AM; Johnson DS; Thiele GM
J Rheumatol; 2011 Dec; 38(12):2509-16. PubMed ID: 21921097
[TBL] [Abstract][Full Text] [Related]
29. CD14 expression in the first 24h of sepsis: effect of -260C>T CD14 SNP.
de Aguiar BB; Girardi I; Paskulin DD; de Franca E; Dornelles C; Dias FS; Bonorino C; Alho CS
Immunol Invest; 2008; 37(8):752-69. PubMed ID: 18991094
[TBL] [Abstract][Full Text] [Related]
30. Lower antibody response to Porphyromonas gingivalis associated with immunoglobulin G Fcgamma receptor IIB polymorphism.
Honma Y; Sugita N; Kobayashi T; Abiko Y; Yoshie H
J Periodontal Res; 2008 Dec; 43(6):706-11. PubMed ID: 18705654
[TBL] [Abstract][Full Text] [Related]
31. 159C>T CD14 genotype--functional effects on innate immune responses in term neonates.
Härtel C; Rupp J; Hoegemann A; Bohler A; Spiegler J; von Otte S; Röder K; Schultz C; Göpel W
Hum Immunol; 2008 Jun; 69(6):338-43. PubMed ID: 18571004
[TBL] [Abstract][Full Text] [Related]
32. Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting.
Shimada K; Miyauchi K; Mokuno H; Watanabe Y; Iwama Y; Shigekiyo M; Matsumoto M; Okazaki S; Tanimoto K; Kurata T; Sato H; Daida H
Int J Cardiol; 2004 Mar; 94(1):87-92. PubMed ID: 14996480
[TBL] [Abstract][Full Text] [Related]
33. Serum antibody response to periodontal pathogens and herpes simplex virus in relation to classic risk factors of cardiovascular disease.
Vilkuna-Rautiainen T; Pussinen PJ; Roivainen M; Petäys T; Jousilahti P; Hovi T; Vartiainen E; Asikainen S
Int J Epidemiol; 2006 Dec; 35(6):1486-94. PubMed ID: 16997850
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of mCD14 expression on monocytes and the blood level of sCD14 in patients with generalized aggressive periodontitis.
Pietruska M; Zak J; Pietruski J; Wysocka J
Adv Med Sci; 2006; 51 Suppl 1():166-9. PubMed ID: 17458084
[TBL] [Abstract][Full Text] [Related]
35. Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection.
Aalto H; Takala A; Kautiainen H; Siitonen S; Repo H
Scand J Infect Dis; 2007; 39(6-7):596-603. PubMed ID: 17577824
[TBL] [Abstract][Full Text] [Related]
36. Periodontitis is characterized by elevated PAI-1 activity.
Bizzarro S; van der Velden U; ten Heggeler JM; Leivadaros E; Hoek FJ; Gerdes VE; Bakker SJ; Gans RO; Ten Cate H; Loos BG
J Clin Periodontol; 2007 Jul; 34(7):574-80. PubMed ID: 17535288
[TBL] [Abstract][Full Text] [Related]
37. [Titer and avidity of serum antibody to Porphyromonas gingivalis before and after periodontal therapy].
Ouyang X; Cao C; Chen Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 May; 35(3):188-90. PubMed ID: 11780220
[TBL] [Abstract][Full Text] [Related]
38. Antibody levels to single bacteria or in combination evaluated against myocardial infarction.
Lund Håheim L; Olsen I; Nafstad P; Schwarze P; Rønningen KS
J Clin Periodontol; 2008 Jun; 35(6):473-8. PubMed ID: 18410396
[TBL] [Abstract][Full Text] [Related]
39. Serum IgG1 and IgG2 antibody responses to Porphyromonas gingivalis in patients with periodontitis.
Booth V; Solakoglu O; Bavisha N; Curtis MA
Oral Microbiol Immunol; 2006 Apr; 21(2):93-9. PubMed ID: 16476018
[TBL] [Abstract][Full Text] [Related]
40. Porphyromonas gingivalis as putative pathogen in ovine periodontitis.
Dreyer WP; Basson NJ
J Dent Assoc S Afr; 1992 Dec; 47(12):513-6. PubMed ID: 9511637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
